Delivery Order SPE2DB20D1109-SPE2DB24FP40B

Award Date 6/26/24
Potential Completion Date 7/18/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order with a ceiling value of $2,195.48 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of YONSA 125 MG TABLET 120S, a medication, with a period of performance through November 18, 2024. The contract type is Firm Fixed Price. This award is not associated with any set-aside designations, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a ceiling value of $2,195.48 and a completion date of October 15, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,195.48, is a delivery order for the supply of 4,566,374,320 units of the pharmaceutical product YONSA 125 MG TABLET 120S. The contract has a firm fixed price pricing type and an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $9,085.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a completion date of March 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There was no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is for the delivery of the pharmaceutical product YONSA 125 MG TABLET 120S. The award, valued at $2,195.48, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 19, 2024. The contract is not designated as a set-aside. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $2,195.48, is for the delivery of 4565843570 YONSA 125 MG TABLET 120S. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $4,390.96, covers the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a performance period ending on July 15, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of June 26, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of 4,568,141,590 units of the pharmaceutical product YONSA 125 MG TABLET 120S. The contract has an ultimate completion date of May 27, 2025. This award is not designated as a set-aside and was competed openly. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $2,271.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB22D3009|SPE2DB25FAV90) for the medication YONSA 125 MG TABLET 120S, with a performance period extending to May 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP40B
    Delivery Order

This federal contract award, with a ceiling value of $2,195.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, and is structured as a Firm Fixed Price Delivery Order with a performance period through July 18, 2024. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 1:13 PM